Rocklatan, a medication used to treat glaucoma, is available with a savings program that can reduce out-of-pocket costs for eligible commercially insured patients [1]. This program, often referred to as a coupon or savings card, is provided by the manufacturer and can be accessed through their website or patient assistance programs [1].
How Much Can I Save with a Rocklatan Coupon?
The savings offered by Rocklatan coupons can vary, but eligible patients with commercial insurance may pay as little as a $0 co-pay for a prescription [1]. The program typically has a maximum savings limit per prescription and an annual maximum [1].
Who is Eligible for Rocklatan Savings Programs?
Eligibility for Rocklatan savings programs generally requires patients to have commercial prescription insurance and to be residing in the United States [1]. The program is not available to patients covered by Medicare, Medicaid, TRICARE, or other federal or state healthcare programs [1]. Patients without insurance may be eligible for other patient assistance programs that offer reduced costs [1].
How Do I Get a Rocklatan Coupon?
To obtain a Rocklatan coupon, patients can visit the official Rocklatan website or inquire with their healthcare provider's office [1]. These programs are typically managed by the drug manufacturer and are designed to make the medication more affordable for those who qualify [1].
What is Rocklatan Used For?
Rocklatan is a prescription medication used to lower elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension [2]. High IOP is a major risk factor for optic nerve damage and vision loss associated with glaucoma [2].
How Does Rocklatan Work?
Rocklatan is a Rho kinase (ROCK) inhibitor [2]. It works by increasing the outflow of aqueous humor from the eye, which helps to reduce intraocular pressure [2].
When Does Rocklatan's Patent Expire?
Information regarding Rocklatan's patent expiry is available through specialized patent databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, including details on exclusivity and potential generic entry [3]. For specific patent expiry dates related to Rocklatan, consulting such resources would be necessary.